Post Launch Support Services
Aptar Pharma’s commitment to delivering our customers much more than a device is a philosophy that continues throughout the lifecycle of each product–from brand extensions and change management into new device innovations and repurposing.
Because Your Journey Doesn’t End at Drug Product Launch
A lifetime of lifecycle management
We have developed an industry-leading track record in taking existing drug products and revitalizing them through our lifecycle management programs.
Maximize your ROI
Whether it is breathing new life into older devices or taking an existing therapy and repurposing it, we have the tools and expertise to guide you through the product lifecycle management process, ensuring you maximize the potential from your investment.
Maintaining our diligence
We support our partners in maintaining post-marketing surveillance and risk-assessment programs to mitigate both reputational and physical risks. We also offer annual product reviews for post-launch regulatory support.
A Broad Post-Launch Support Portfolio
Onboarding and Patient Adherence Programs
Our solutions help patients self-administer their therapy correctly and with confidence.
With an integrated approach from scale up to full scale manufacturing, our expert teams can help get your products to market.
Device Failure and Investigations
Should any device be out of specification or deviate from the expected functioning, we take corrective and preventative action to identify and solve the problem.
Data Trending on CQA
Our data analysts and data scientists monitor the Critical Quality Attributes.
Update of DFMEA files
Failure Mode and Effect Analysis files can be shared to help identify design functions, failure modes and their effects on your products, providing you with the severity ranking and level of residual risks.
Latest in Aptar Pharma Knowledge Hub
A New Test Method to Establish Targeted Delivery to the Upper Res...
Webinars, Pharmaceutical, Brand Differentiation, Device Innovations, Market Insights, Product Solutions
Aptar Pharma: RFID-Enabled Rigid Needle Shields for Unit Serializ...
Publications, Pharmaceutical, Brand Differentiation, Device Innovations, Market Insights, Product Solutions
Aptar Pharma: Vaccine Platform Addresses Covid-19 Development and...
Publications, Pharmaceutical, Device Innovations, Innovation & Insights, Market Insights, Product Solutions
Delivery Device – Aerosol Deposition Characterization of Innova...
Publications, Pharmaceutical, Brand Differentiation, Device Innovations, Innovation & Insights, Product Solutions